CI · Full Picture
Cigna Group — the full picture
Trailing window · 2026-05-11 to 2026-08-09
One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.
What to look at first
- Revenue Performance and Mix · Revenue growth & mixPriority 51+6.7% revenue (realized); quote_verifiedCigna recently reported $7.78 in adjusted EPS and a 6.7% increase in revenue for the quarter.
- Capital Return Program · Buybacks & dividendsPriority 332 forward row(s); quote_verifiedCigna declared a quarterly dividend of $1.56 per share.
- Business Portfolio Review · UnclassifiedPriority 30quote_verifiedDavid Cordani's strategic maneuvers included the acquisition of Express Scripts.
- Pennsylvania Pharmacy Litigation · Litigation & settlementsPriority 28quote_verifiedA Pennsylvania federal judge dismissed a lawsuit against Cigna, Evernorth, and Express Scripts.
- PBM Regulatory Scrutiny · Regulatory action & investigationsPriority 25quote_verifiedCigna Group's stock dropped 9.0% despite strong Q2 2026 results.
Threads by pillar
Revenue & Demand Priority 51 · 1 thread
- Revenue Performance and MixPriority 51 · News
Capital & Balance Sheet Priority 33 · 1 thread
- Capital Return ProgramPriority 33 · News
Legal, Regulatory & Policy Priority 31 · 2 threads
- Pennsylvania Pharmacy LitigationPriority 28 · News
- PBM Regulatory ScrutinyPriority 25 · News
Unclassified Priority 30 · 1 thread
- Business Portfolio ReviewPriority 30 · News
Expected impact by metric
| metric | forward net | forward gross | realized |
|---|---|---|---|
| revenue | — | — | +6.7% |